Douglas Roepke MD Eli Lilly and Company

At age five, Douglas Roepke told his mother he wanted to be a physician. 45 plus years later, he is an experienced clinical general pediatrician with 15 years of broad patient contact experience, including with the pediatric special needs population that extensively utilizes the products of the pharmaceutical industry. Since 2008, Doug has been at Eli Lilly and Company, focused on patient safety. He has both adverse event reporting and pharmacovigilance experience in safety. Doug has been in a product safety assessment physician role since 2015 focused on health hazard evaluations and other product safety assessments, drug adverse event /product complaint (AE/PC) surveillance, device risk assessment activities, device periodic reporting, device AE/PC surveillance, corporate drug substance and drug product specifications, manufacturing change comparability, and anti-counterfeiting risk assessment and investigation support.